24 results
10-Q
2022 Q3
PRME
Prime Medicine Inc
14 Nov 22
Quarterly report
4:46pm
practices. These laws and regulations restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer
424B4
PRME
Prime Medicine Inc
21 Oct 22
Prospectus supplement with pricing info
4:47pm
or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements … in the preparation of our consolidated financial statements.
Revenue Recognition
We recognize revenue when our customer obtains control of promised goods
S-1/A
w7ty5de98q8h6wl0g
13 Oct 22
IPO registration (amended)
10:51am
S-1
EX-10.22
idg5m4oq
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.19
fj4nmbr144you ele
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.14
8qi rlrjn0lt4xyg8
23 Sep 22
IPO registration
4:12pm
S-1
hcp2peyyb9d
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.4
grmnn3ieu iml2coc
23 Sep 22
IPO registration
4:12pm
DRS/A
f06m4x
5 Aug 22
Draft registration statement (amended)
12:00am
DRS/A
xulzmrs7vx52v5ux
6 May 22
Draft registration statement (amended)
12:00am
DRS/A
ylfx3n7o 0ji3y7
8 Apr 22
Draft registration statement (amended)
12:00am
DRS/A
akd14z99l9jfsq38fu
25 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.20
jgq671is
7 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.4
y0iskbiy
7 Mar 22
Draft registration statement (amended)
12:00am
DRSLTR
9c0 i2zfr9lgrliapwks
7 Mar 22
Correspondence regarding draft registration statement
12:00am
DRS/A
5rq nn8lpi
7 Mar 22
Draft registration statement (amended)
12:00am
UPLOAD
xesx8ycs9zrgdxcug
17 Feb 22
Letter from SEC
12:00am